Voyager Therapeutics
VYGR
70 hedge funds and large institutions have $145M invested in Voyager Therapeutics in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 13 closing their positions.
2,427% more call options, than puts
Call options by funds: $834K | Put options by funds: $33K
1% more funds holding
Funds holding: 69 → 70 (+1)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
2% more capital invested
Capital invested by funds: $143M → $145M (+$2.48M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.3% less ownership
Funds ownership: 62.45% → 62.15% (-0.3%)
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.43M |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$625K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$620K |
| 4 |
Citigroup
New York
|
+$459K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$405K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.71M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$1.12M |
| 3 |
Walleye Capital
New York
|
-$752K |
| 4 |
Morgan Stanley
New York
|
-$456K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$344K |
VYGR Hedge Fund Activity: Q4 2022 in Review
70 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q4 2022, worth a combined $145M — up 1.7% from $143M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new VYGR positions and 13 closed out — a net gain of 1 holder — while 17 added to existing stakes and 18 trimmed.
The largest buyer was BlackRock, adding an estimated $1.43M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $1.71M sold.
- 70 institutional investors held Voyager Therapeutics (VYGR) as of Q4 2022, up from 69 in Q3 2022.
- Funds reported $145M of Voyager Therapeutics stock for Q4 2022, up 1.7% quarter-over-quarter.
- 14 funds opened new Voyager Therapeutics positions in Q4 2022 and 13 closed out, a net change of +1 holder.
- The largest Voyager Therapeutics buyer in Q4 2022 was BlackRock, an estimated $1.43M added.
- The largest Voyager Therapeutics seller in Q4 2022 was Point72 Asset Management, an estimated $1.71M sold.
Based on aggregated 13F filings for Q4 2022.